Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $35.95 USD
Change Today -0.17 / -0.47%
Volume 578.3K
HAE On Other Exchanges
New York
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pedro P. Granadillo B.S.

Director, Chairman of Compensation Committee and Member of Governance & Compliance Committee,Haemonetics Corporation
AgeTotal Calculated CompensationThis person is connected to 36 board members in 4 different organizations across 7 different industries.

See Board Relationships


Mr. Pedro P. Granadillo, B.S., served as the Senior Vice President of Global Manufacturing & Human Resources at Eli Lilly & Co. from June 1998 to September 30, 2004 and its Vice President of Human Resources from 1993 to 1998. Mr. Granadillo joined Eli Lilly in 1970 in Indianapolis as a Staff Engineer and held a number of manufacturing positions, first in Spain and then in England. At Eli Lilly, he served as Vice President of Pharmaceutical Manufacturing, Executive Director ...

Read Full Background

Corporate Headquarters*

400 Wood Road
Braintree, Massachusetts 02184

United States

Phone: 781-848-7100
Fax: --

Board Members Memberships*

Director, Chairman of Compensation Committee and Member of Governance & Compliance Committee
Director, Member of Audit Committee and Member of Compensation Committee


Purdue University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options42,225
Exercisable Options Value$449,989
Unexercisable Options10,353
Unexercisable Options Value$90,175
Total Value of Options$540,163
Total Number of Options52,578

Total Compensation*

Total Annual Cash Compensation$81,000
Total Calculated Compensation$250,986
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $35.95 USD -0.17


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Yutaro Shintaku President and Representative Director
Terumo Corporation
Ulf M. Schneider Chairman of the Management Board - Fresenius Management Se, Chief Executive Officer of Fresenius Management Se and President of Fresenius Management Se
Fresenius SE & Co KGaA
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at